Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon B Mills

Showing results (1-10 of 826) with videos related to

Pageof 83
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Mechanisms underlying chemoprevention of ovarian cancerGordon B Mills
Genome Research|February 4, 2012
An emerging toolkit for targeted cancer therapiesGordon B Mills
Cancer Cell|March 16, 2010
The rebirth of a phoenix: ovarian cancers are addicted to ErbB-3Gordon B Mills, Yosef Yarden
Cancer Research|May 7, 2013
AMPK: a contextual oncogene or tumor suppressor?Jiyong Liang, Gordon B Mills
The Journal of Clinical Investigation|May 1, 2024
Enhancing anticancer activity of macrophages through rational drug combinationsGordon B Mills, Marilyne Labrie
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2017
Surviving Ovarian Cancer: An Affair between Defective DNA Repair and RB1Guang Peng, Gordon B Mills
Expert Reviews in Molecular Medicine|October 16, 2007
Targeting the lipids LPA and S1P and their signalling pathways to inhibit tumour progressionMandi Murph, Gordon B Mills
Autophagy|August 19, 2020
The roles of <i>MAGEA6</i> variants in pancreatic cancer development and their potential impact on cancer immunotherapyYiu Huen Tsang, Gordon B Mills
Gynecologic Oncology|February 15, 2003
General keynote: molecular therapeutics and pharmocogenomicsRobert C Bast, Gordon B Mills
Seminars in Oncology|April 1, 2005
Mammalian target of rapamycinFunda Meric-Bernstam, Gordon B Mills
Pageof 83

Showing results (1-10 of 826) with videos related to

Sort By:
Pageof 83
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Mechanisms underlying chemoprevention of ovarian cancerGordon B Mills
Genome Research|February 4, 2012
An emerging toolkit for targeted cancer therapiesGordon B Mills
Cancer Cell|March 16, 2010
The rebirth of a phoenix: ovarian cancers are addicted to ErbB-3Gordon B Mills, Yosef Yarden
Cancer Research|May 7, 2013
AMPK: a contextual oncogene or tumor suppressor?Jiyong Liang, Gordon B Mills
The Journal of Clinical Investigation|May 1, 2024
Enhancing anticancer activity of macrophages through rational drug combinationsGordon B Mills, Marilyne Labrie
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2017
Surviving Ovarian Cancer: An Affair between Defective DNA Repair and RB1Guang Peng, Gordon B Mills
Expert Reviews in Molecular Medicine|October 16, 2007
Targeting the lipids LPA and S1P and their signalling pathways to inhibit tumour progressionMandi Murph, Gordon B Mills
Autophagy|August 19, 2020
The roles of <i>MAGEA6</i> variants in pancreatic cancer development and their potential impact on cancer immunotherapyYiu Huen Tsang, Gordon B Mills
Gynecologic Oncology|February 15, 2003
General keynote: molecular therapeutics and pharmocogenomicsRobert C Bast, Gordon B Mills
Seminars in Oncology|April 1, 2005
Mammalian target of rapamycinFunda Meric-Bernstam, Gordon B Mills
Pageof 83